BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2866753)

  • 1. Progressive supranuclear palsy: postmortem chemical analysis.
    Young AB
    Ann Neurol; 1985 Nov; 18(5):521-2. PubMed ID: 2866753
    [No Abstract]   [Full Text] [Related]  

  • 2. Progressive supranuclear palsy: relationship between extrapyramidal disturbances, dementia, and brain neurotransmitter markers.
    Kish SJ; Chang LJ; Mirchandani L; Shannak K; Hornykiewicz O
    Ann Neurol; 1985 Nov; 18(5):530-6. PubMed ID: 2416269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic and cholinergic lesions in progressive supranuclear palsy.
    Ruberg M; Javoy-Agid F; Hirsch E; Scatton B; LHeureux R; Hauw JJ; Duyckaerts C; Gray F; Morel-Maroger A; Rascol A
    Ann Neurol; 1985 Nov; 18(5):523-9. PubMed ID: 3000280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical changes in Alzheimer's disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer's type.
    Davies P
    Res Publ Assoc Res Nerv Ment Dis; 1979; 57():153-66. PubMed ID: 33427
    [No Abstract]   [Full Text] [Related]  

  • 5. Progressive supranuclear palsy: anatomoclinical and biochemical considerations.
    Agid Y; Javoy-Agid F; Ruberg M; Pillon B; Dubois B; Duyckaerts C; Hauw JJ; Baron JC; Scatton B
    Adv Neurol; 1987; 45():191-206. PubMed ID: 2881445
    [No Abstract]   [Full Text] [Related]  

  • 6. [Neurotransmitters in Huntington chorea (review)].
    Barkhatova VP; Larskiĭ EG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(3):444-50. PubMed ID: 2581405
    [No Abstract]   [Full Text] [Related]  

  • 7. Neurotransmitters in the brains of patients with dementia disorders.
    Gottfries CG
    Dan Med Bull; 1985 Feb; 32 Suppl 1():44-8. PubMed ID: 2580668
    [No Abstract]   [Full Text] [Related]  

  • 8. An update on the neurochemistry of Alzheimer disease.
    Davies P
    Adv Neurol; 1983; 38():75-86. PubMed ID: 6137134
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ageing and neurotransmitters].
    Nakamura S; Miyata S
    Nihon Naika Gakkai Zasshi; 1985 Oct; 74(10):1348-52. PubMed ID: 2869092
    [No Abstract]   [Full Text] [Related]  

  • 10. Aging and neurotransmitter systems.
    McGeer EG; McGeer PL
    Adv Biochem Psychopharmacol; 1980; 23():305-14. PubMed ID: 6104910
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemical and structural changes in the brain in patients with movement disorder.
    Cross AJ; Crow TJ; Ferrier IN; Johnson JA; Johnstone EC; Owen F; Owens DG; Poulter M
    Psychopharmacology Suppl; 1985; 2():104-10. PubMed ID: 2860653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Biochemical bases of Parkinson disease].
    Colucci d'Amato C; Puccini A; Cristillo A; Vizioli R
    Recenti Prog Med; 1984 Oct; 75(10):889-901. PubMed ID: 6151219
    [No Abstract]   [Full Text] [Related]  

  • 13. Neurochemical anatomy of movement disorders.
    Young AB; Penney JB
    Neurol Clin; 1984 Aug; 2(3):417-33. PubMed ID: 6152481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurohumoral interactions and basal ganglia function and dysfunction.
    Hornykiewicz O
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():269-80. PubMed ID: 12547
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoamine transmitters and their metabolites in the basal ganglia of Huntington's disease and control postmortem brain.
    Walsh FX; Bird ED; Stevens TJ
    Adv Neurol; 1982; 35():165-9. PubMed ID: 6183949
    [No Abstract]   [Full Text] [Related]  

  • 16. [Progresses in the study of unbalance of basal ganglia neurotransmitters in Parkinson's disease].
    Sun ZL; Jia J; Yu F
    Sheng Li Ke Xue Jin Zhan; 2011 Dec; 42(6):427-30. PubMed ID: 22363981
    [No Abstract]   [Full Text] [Related]  

  • 17. [Modifications in neurotransmission in degenerative dementia].
    Maloteaux JM
    Acta Neurol Belg; 1989; 89(3-4):186-93. PubMed ID: 2576495
    [No Abstract]   [Full Text] [Related]  

  • 18. Measurement of gamma-aminobutyric acid turnover rates in brain nuclei as an index of interactions between gamma-aminobutyric acid and other transmitters.
    Revuelta AV; Cheney DL; Costa E
    Adv Biochem Psychopharmacol; 1981; 27():169-81. PubMed ID: 6108692
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
    Whitehouse PJ
    Adv Neurol; 1987; 45():393-7. PubMed ID: 2881448
    [No Abstract]   [Full Text] [Related]  

  • 20. [Huntington chorea. Review of the most recent aspects of research].
    Albano C; Farinini D; Tassinari T; Caponnetto C; Bacigalupo F
    Riv Neurol; 1985; 55(4):247-55. PubMed ID: 2997905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.